Skip to content

The Impact of Dietary Restriction of Animal Protein and Fat on Osteoarthritis

The Impact of Dietary Restriction of Animal Protein and Fat on Subjective Complaints of Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01939262
Enrollment
40
Registered
2013-09-11
Start date
2010-12-31
Completion date
2012-02-29
Last updated
2013-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Arthritis, Pain, Function, Diet, Vegan, Vegetarian, Restriction

Brief summary

Patients will be randomized into the control or intervention group. Based on patient preference, the intervention group will be trained for one hour in either individual or group format on vegan diet. They will also be directed to www.pcrm.org and www.drmarymd.com for low glycemic, animal free, low fat food options and support. The control group will continue their normal omnivorous diet program. Twenty-four hour food recalls will be obtained at the start and end of the trial, and once a week for the 6 weeks of the trial by telephone. Patients will undergo a final interview at the end of the 6 week study period. The intervention group should strive to obtain 90% of their calories from plants. They will be encouraged to eat freely and not count calories. Patients will undergo additional individual consultation as needed to promote compliance and answer specific questions. Over the 6 weeks, the Patient Global Improvement of Change (PGIC) and the 36 item short form health survey (SF-36) will be performed weekly by telephone. Patient will perform a Visual Analog Scale (VAS) of their pain level randomly daily on their own. C-reactive protein levels will be assessed at the beginning and end of the study at Munson Medical Center Laboratories as a secondary measure of diet changes. There have been no published prospective randomized controlled trials assessing whether a vegan diet would benefit osteoarthritis. The specific aim of this study is to determine if a vegan diet will result in subjective reduction in perceived pain and limitations to function in patients with osteoarthritis.

Interventions

OTHERLimitation of Animal Fat and Protein in the Diet

Animal products were proscribed and the use of unrefined foods was encouraged. Participants were asked to limit high-fat plant foods, such as nuts, avocados, and refined oils. There was no restriction in energy intake, were encouraged to eat freely and not count calories.

OTHERControl

Participants assigned to the control group will be instructed to follow their usual diets.

Sponsors

Blue Cross Blue Shield of Michigan Foundation
CollaboratorOTHER
Essentia Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Community dwelling * Medical Provider diagnosis of Osteoarthritis

Exclusion criteria

* Pre-existing vegans or vegetarians * Ages less than 18 or greater than 70 * History of an eating disorder * History of diabetes * Inability to afford food * Lack of control over the food eaten * Pregnant or nursing * Known food allergies * Patients following a medically prescribed diet

Design outcomes

Primary

MeasureTime frameDescription
Subjective Complaints of Pain and Functionality in Osteoarthritis PatientsSix weeksSignificant responders were defined as patients that experienced a clinically significant improvement in at least two of the three administered tests: pain, as measured by a 30% improvement on the VAS(Visual Analog Scale) and improvement in patient's global status, measured by a rating of somewhat better to a great deal better on the PGIC scale, and physical function, a \>6 point improvement on the 36-item short form health survey (SF-36v2) Role Physical or Physical Component Summary Score

Secondary

MeasureTime frameDescription
c-reactive protein6 weeksClinical laboratory tests of c-reactive protein was drawn at the intake and exit of the study .

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026